In the second publication (submitted in August 2020), the authors included five more serum selenium samples and two more discharged male patients, and concluded that a normal zinc status and selenoprotein P (SELENOP) status (but not selenium levels) are indicators of high survival odds in COVID-19 and that the supplementation of selenium may support convalescence in patients with a proven selenium deficit [60]. The gene discussed is SELENOP; the disease is COVID-19.